STVN
Stevanato Group SpA
$
24.100
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
24.5809
Open
24.410
VWAP
24.08
Vol
301.31K
Mkt Cap
7.30B
Low
23.670
Amount
7.25M
EV/EBITDA(TTM)
26.25
Total Shares
272.77M
EV
7.68B
EV/OCF(TTM)
29.52
P/S(TTM)
4.79
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q1
FY2025Q4
305.04M
+8.94%
0.165
+29.57%
274.17M
+6.85%
0.130
+14.55%
333.73M
+0.95%
0.197
-3.66%
Estimates Revision
The market is revising Downward the revenue expectations for Stevanato Group S.p.A. (STVN) for FY2025, with the revenue forecasts being adjusted by -0.05% over the past three months. During the same period, the stock price has changed by 10.30%.
Revenue Estimates for FY2025
Revise Downward
-0.05%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-0.02%
In Past 3 Month
Stock Price
Go Up
+10.30%
In Past 3 Month
5 Analyst Rating
18.26% Upside
Wall Street analysts forecast STVN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STVN is 28.50 USD with a low forecast of 24.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
2 Hold
0 Sell
Moderate Buy
18.26% Upside
Current: 24.100
Low
24.00
Averages
28.50
High
32.00
18.26% Upside
Current: 24.100
Low
24.00
Averages
28.50
High
32.00
UBS
John Sourbeer
Hold
Maintains
$24 → $24
2025-03-07
Reason
UBS
John Sourbeer
Price Target
$24 → $24
2025-03-07
Maintains
Hold
Reason
Wolfe Research
Doug Schenkel
Buy
Initiates
$28
2024-12-13
Reason
Wolfe Research
Doug Schenkel
Price Target
$28
2024-12-13
Initiates
Buy
Reason
Wolfe Research analyst Doug Schenkel initiated coverage of Stevanato Group with an Outperform rating and $28 price target.
B of A Securities
Derik De Bruin
Strong Buy
Maintains
$24 → $26
2024-12-13
Reason
B of A Securities
Derik De Bruin
Price Target
$24 → $26
2024-12-13
Maintains
Strong Buy
Reason
Morgan Stanley
Tejas Savant
Hold
Initiates
$24 → $23
2024-12-03
Reason
Morgan Stanley
Tejas Savant
Price Target
$24 → $23
2024-12-03
Initiates
Hold
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Stevanato Group SpA (STVN.N) is 35.93, compared to its 5-year average forward P/E of 38.73. For a more detailed relative valuation and DCF analysis to assess Stevanato Group SpA 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
38.73
Current PE
35.93
Overvalued PE
46.84
Undervalued PE
30.62
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
20.00
Current EV/EBITDA
18.65
Overvalued EV/EBITDA
24.22
Undervalued EV/EBITDA
15.78
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Strongly Overvalued
5Y Average PS
5.27
Current PS
20.84
Overvalued PS
7.00
Undervalued PS
3.54
Financials
Annual
Quarterly
FY2025Q3
YoY :
+9.12%
303.20M
Total Revenue
FY2025Q3
YoY :
+16.03%
52.70M
Operating Profit
FY2025Q3
YoY :
+19.92%
36.00M
Net Income after Tax
FY2025Q3
YoY :
+18.18%
0.13
EPS - Diluted
FY2025Q3
YoY :
-100.00%
N/A
Free Cash Flow
FY2025Q3
YoY :
+4.06%
29.19
Gross Profit Margin - %
FY2025Q3
YoY :
-100.00%
N/A
FCF Margin - %
FY2025Q3
YoY :
+9.91%
11.87
Net Margin - %
FY2025Q3
YoY :
-100.00%
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
9.6K
Volume
2
0-12
Months
1.8M
Volume
3
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
25.2K
Volume
Months
0-12
3
645.6K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
STVN News & Events
Events Timeline
2025-11-06 (ET)
2025-11-06
06:59:13
Stevanato Group projects adjusted EPS of EUR0.50-EUR0.54 for 2025
2025-11-06
06:57:58
Stevanato Group announces Q3 adjusted EPS of EUR 0.14, up from EUR 0.12 a year ago.
2025-10-21 (ET)
2025-10-21
06:40:51
Stevanato Group increases production capacity for drug delivery systems
Sign Up For More Events
Sign Up For More Events
News
3.5
10-21NewsfilterStevanato Group Enhances Drug Delivery Systems Capacity to Bolster Global Integrated Solutions
4.0
09-11NASDAQ.COMStevanato (STVN) Receives Upgrade to Buy: Key Information You Need to Know
1.0
09-09NewsfilterStevanato Group S.p.A. (STVN) Shares Insights at Morgan Stanley's 23rd Annual Global Healthcare Conference Transcript
Sign Up For More News
People Also Watch
SPXC
SPX Technologies Inc
221.920
USD
+1.97%
CGNX
Cognex Corp
39.270
USD
-0.68%
VIPS
Vipshop Holdings Ltd
18.660
USD
+2.08%
JHG
Janus Henderson Group PLC
43.970
USD
+1.57%
LEVI
Levi Strauss & Co
20.240
USD
+1.15%
BFAM
Bright Horizons Family Solutions Inc
98.460
USD
+0.62%
JXN
Jackson Financial Inc
92.880
USD
+0.81%
WTS
Watts Water Technologies Inc
273.210
USD
+3.67%
FCN
FTI Consulting Inc
163.410
USD
-0.35%
DINO
HF Sinclair Corp
54.730
USD
+2.05%
FAQ
What is Stevanato Group SpA (STVN) stock price today?
The current price of STVN is 24.1 USD — it has decreased -1.27 % in the last trading day.
What is Stevanato Group SpA (STVN)'s business?
What is the price predicton of STVN Stock?
What is Stevanato Group SpA (STVN)'s revenue for the last quarter?
What is Stevanato Group SpA (STVN)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Stevanato Group SpA (STVN)'s fundamentals?
How many employees does Stevanato Group SpA (STVN). have?